Marvel Biosciences Corp Strategic Asset Allocation Index
Marvel Biosciences Corp strategic asset allocation index. Marvel Biosciences Corp (MRVL) has a Strategic Asset Allocation Index of 0.0% as of October 2021. Strategic assets (PP&E of CA$114.00 plus long-term investments of CA$-) total CA$114.00, measured against net assets of CA$1.85 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check tangible net worth ratio of Marvel Biosciences Corp to evaluate the tangible quality of the company's equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Marvel Biosciences Corp (2020–2021)
Strategic asset allocation index of Marvel Biosciences Corp from 2020 to 2021. This chart shows how Marvel Biosciences Corp's Strategic Asset Allocation Index has evolved across 2 annual periods from 2020 to 2021. As of October 2021, the index stands at 0.0%, representing strategic assets of CA$114.00 against net assets of CA$1.85 Million CAD.
Marvel Biosciences Corp Strategic Asset Allocation Index by Year (2020–2021)
Marvel Biosciences Corp strategic asset allocation index by year from 2020 to 2021. The table below presents the year-by-year Strategic Asset Allocation Index for Marvel Biosciences Corp from 2020 to 2021, covering 2 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see MRVL market cap overview.
| Year | SAAI | Strategic Assets (CAD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 0.0% | CA$152.00 | CA$152.00 | CA$- | CA$2.36 Million | ▼ -0.3 pp |
| 2020 | 0.3% | CA$337.00 | CA$337.00 | CA$- | CA$118.80K | — |